文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19住院患者血液黏度与无器械日数的关联

Association of blood viscosity and device-free days among hospitalized patients with COVID-19.
PubMed 文献 · J Intensive Care · 2023-05-02
一句话结论住院COVID-19患者入院时估算高剪切血液黏度每升高1厘泊,21天内无呼吸器官支持日数减少(aOR 0.68,95%CI 0.59-0.79,P<0.001)。

这项回顾性队列研究纳入美国纽约市西奈山健康系统2020年2月27日至2021年11月20日期间住院、入院48小时内诊断的COVID-19患者9278例,排除主要协变量缺失、出院信息缺失及不符合非牛顿血液模型标准者后,5621例纳入主分析,另对4352例有白细胞计数、C反应蛋白和D-二聚体检测者单独分析。研究按估算高剪切血液黏度(eHSBV)和估算低剪切血液黏度(eLSBV)四分位数分组,用Walburn-Schneck模型计算血液黏度,主要结局为截至第21天无呼吸器官支持日数的有序量表(院内死亡赋值为-1)。多变量累积logistic回归显示,eHSBV每升高1厘泊,aOR为0.68(95%CI 0.59-0.79,P<0.001)。作者认为,入院时eHSBV和eLSBV升高与21天时呼吸器官支持需求增加相关,eWBV有助于早期识别非致命结局风险升高的急性COVID-19住院患者。

要点

  • 5621例住院COVID-19患者中,eHSBV每升高1厘泊,21天无呼吸器官支持日数减少,aOR 0.68(95%CI 0.59-0.79,P<0.001)。
  • 主要结局为截至第21天无呼吸器官支持日数的有序量表,院内死亡赋值为-1。
  • 作者认为入院时eHSBV和eLSBV升高与21天时呼吸器官支持需求增加相关。
  • 作者认为eWBV可用于早期识别急性COVID-19住院患者中非致命结局风险升高者。
  • 血液黏度采用Walburn-Schneck模型估算,按eHSBV和eLSBV四分位数分组分析。

适用人群与场景

  • 2020年2月27日至2021年11月20日期间在美国纽约市西奈山健康系统住院、入院48小时内诊断的COVID-19患者9278例。
  • 排除主要协变量缺失、出院信息缺失以及不符合非牛顿血液模型标准者后,5621例纳入主分析。
  • 另对4352例有白细胞计数、C反应蛋白和D-二聚体检测者单独进行分析。

诊断标准与关键阈值

  • 按估算高剪切血液黏度(eHSBV)和估算低剪切血液黏度(eLSBV)的四分位数对患者进行分组。
  • 血液黏度使用Walburn-Schneck模型计算。
  • 主要结局为截至第21天无呼吸器官支持日数的有序量表,院内死亡赋值为-1。

研究设计与关键结果

  • 回顾性队列研究,最终纳入5621例,其中男性3459例(61.5%),平均年龄63.2岁(SD 17.1)。
  • 线性模型显示,eHSBV每升高1厘泊,校正比值比(aOR)为0.68(95%CI 0.59-0.79,P<0.001)。
  • 作者报告,入院时eHSBV和eLSBV升高与21天时呼吸器官支持需求增加相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,eWBV有助于在疾病早期识别急性COVID-19住院患者中非致命结局风险升高者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Increased estimated whole blood viscosity (eWBV) predicts higher mortality in patients hospitalized for coronavirus disease 2019 (COVID-19). This study assesses whether eWBV is an early predictor of non-fatal outcomes among patients hospitalized for acute COVID-19 infection.

METHODS: This retrospective cohort study included 9278 hospitalized COVID-19 patients diagnosed within 48 h of admission between February 27, 2020 to November 20, 2021 within the Mount Sinai Health System in New York City. Patients with missing values for major covariates, discharge information, and those who failed to meet the criteria for the non-Newtonian blood model were excluded. 5621 participants were included in the main analysis. Additional analyses were performed separately for 4352 participants who had measurements of white blood cell count, C-reactive protein and D-dimer. Participants were divided into quartiles based on estimated high-shear blood viscosity (eHSBV) and estimated low-shear blood viscosity (eLSBV). Blood viscosity was calculated using the Walburn-Schneck model. The primary outcome was evaluated as an ordinal scale indicating the number of days free of respiratory organ support through day 21, and those who died in-hospital were assigned a value of -1. Multivariate cumulative logistic regression was conducted to evaluate the association between quartiles of eWBV and events.

RESULTS: Among 5621 participants, 3459 (61.5%) were male with mean age of 63.2 (SD 17.1) years. The linear modeling yielded an adjusted odds ratio (aOR) of 0.68 (95% CI 0.59-0.79, p value < 0.001) per 1 centipoise increase in eHSBV.

CONCLUSIONS: Among hospitalized patients with COVID-19, elevated eHSBV and eLSBV at presentation were associated with an increased need for respiratory organ support at 21 days. These findings are highly relevant, as they demonstrate the utility of eWBV in identifying hospitalized patients with acute COVID-19 infection at increased risk for non-fatal outcomes in early stages of the disease.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Waksman O, Choi D, Mar P, et al. Association of blood viscosity and device-free days among hospitalized patients with COVID-19. J Intensive Care. 2023. PMID: 37131249. doi:10.1186/s40560-023-00665-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。